The novel heteromeric bivalent ligand SB9 potently antagonizes P2Y(1) receptor-mediated responses.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/C8FCC44F.svg?ark=w1%2F20260515%2FC8FCC44F)](https://nobleid.org/work/w1/20260515/C8FCC44F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors